HOME > ARCHIVE
ARCHIVE
- Vital-Net Happy about Tie-up with Toho and Other Wholesalers
June 6, 2005
- Alfresa HD: Profits Slip Despite Growth in Sales
June 6, 2005
- Vfend and 8 Other Drugs Recommended for Approval
June 6, 2005
- Suzuken Aims for Domestic Market Share of 25% by 2010
June 6, 2005
- 18th INTERPHEX JAPAN
June 6, 2005
- NEW PRODUCTS
June 6, 2005
- BUSINESS NEWS IN BRIEF
June 6, 2005
- MEDICAL DEVICE NEWS IN BRIEF
June 6, 2005
- Zeria: Strong Consumer Health Sales Offset Drop in Ethical Sales
June 6, 2005
- JACDS Proposes New OTC Drug-Selling Professionals
June 6, 2005
- Fuso: Sales, Profits Up Despite Lower Sales of Kindaly
June 6, 2005
- R&D NEWS IN BRIEF
June 6, 2005
- Nikken Chemicals: Profits Up Sharply Despite Lower Sales
June 6, 2005
- NEW PRODUCTS
June 6, 2005
- Teikoku Hormone: Profits Up Despite Slight Dip in Sales
June 6, 2005
- REGULATORY NEWS IN BRIEF
June 6, 2005
- Yakult Honsha: Pharma Div. Sees 2.1% Decline in Sales
June 6, 2005
- Kobayashi: Sales Up 1.9% at \215,708 Mil.
June 6, 2005
- Seikagaku Corp.: 8.8% Increase in Sales to \22,564 Mil.
June 6, 2005
- Mediceo HD: Sales Rise 29.7% to \1,665,815 Mil.
June 6, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
